Marksans Pharma Limited Financial Overview
Marksans Pharma Limited's market cap is currently ₹82.86B. The company's EPS TTM is ₹2.2; its P/E ratio is 23.56; and it has a dividend yield of 0.44%. Marksans Pharma Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
